Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Sean Liu, Hung-Mo Lin, Ian Baine, Ania Wajnberg, Jeffrey P. Gumprecht, Farah Rahman, Denise Rodriguez, Pranai Tandon, Adel Bassily‐Marcus, Jeffrey Bander, Charles Sanky, Amy C. Dupper, Allen Zheng, Freddy T. Nguyen, Fatima Amanat, Daniel Stadlbauer, Deena R. Altman, Benjamin K. Chen, Florian Krammer, Damodara Rao Mendu, Adolfo Firpo‐Betancourt, Matthew A. Levin, Emilia Bagiella, Arturo Casadevall, Carlos Cordon‐Cardo, Jeffrey S. Jhang, Suzanne Arinsburg, David L. Reich, Judith A. Aberg, Nicole M. Bouvier
Topics & Concepts
MedicineHazard ratioInternal medicineOdds ratioConfidence intervalRetrospective cohort studyConvalescent plasmaRandomized controlled trialAntibodyPropensity score matchingCoronavirusImmunologyCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction